Bufalin (Bufadienolide, demonstrated anti-tumor activity in various cancers) induces apoptosis in a dose-dependent manner by down-regulating HSP27 expression in MTX sensitive and resistant OS cells [69]. The gene discussed is HSPB1; the disease is cancer.